Status:
COMPLETED
Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Non-Dystrophic Myotonia
Myotonia Congenita
Eligibility:
All Genders
18-80 years
Brief Summary
In myotonia congenita (MC), mutations in the CLCN1 gene coding a key chloride channel expressed in muscle cells cause myotonia. On examination, the myotonia can be demonstrated as delayed muscle relax...
Eligibility Criteria
Inclusion
- Age \<18 years
- Molecularly verified MC (Thomsens or Beckers disease)
Exclusion
- Conditions that may impair results of the study, evaluated by the investigator
- Clausphobia
- Pregnancy or breastfeeding
- Metallic objects in and around the body that are not MR-compatible
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04799366
Start Date
February 1 2021
End Date
December 1 2021
Last Update
March 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark